Bupensan® contains the active substance buprenorphine.
Bupensan® is prescribed for the treatment of your opioid dependence. Treatment of your opioid dependence should be conducted in the context of appropriate medical supervision and comprehensive psychosocial care. Bupensan® is intended for the treatment of patients aged 15 and over who have voluntarily consented to addiction treatment.
| Strength | Pack size | Dosage form | Appearance |
| 2 mg | 7, 28 | Sublingual tablets |
|
| 4 mg | 7, 28 | Sublingual tablets |
|
| 8 mg | 7, 28 | Sublingual tablets |
|
| 12 mg | 7, 28 | Sublingual tablets |
|
| 16 mg | 7, 28 | Sublingual tablets |
|
